Next Article in Journal
The Tyrosyl-DNA Phosphodiesterase 1β (Tdp1β) Gene Discloses an Early Response to Abiotic Stresses
Next Article in Special Issue
Molecular Screening of 43 Brazilian Families Diagnosed with Leber Congenital Amaurosis or Early-Onset Severe Retinal Dystrophy
Previous Article in Journal
RNAi-Mediated Specific Gene Silencing as a Tool for the Discovery of New Drug Targets in Giardia lamblia; Evaluation Using the NADH Oxidase Gene
Previous Article in Special Issue
Correction: Gustafson et al., Whole Genome Sequencing Revealed Mutations in Two Independent Genes as the Underlying Cause of Retinal Degeneration in an Ashkenazi Jewish Pedigree. Genes 2017, 8, 210

Target 5000: Target Capture Sequencing for Inherited Retinal Degenerations

The School of Genetics & Microbiology, Trinity College Dublin, Dublin 2, Ireland
The Mater Misericordiae University Hospital, Dublin 7, Ireland
The Research Foundation, Royal Victoria Eye and Ear Hospital, Dublin 2, Ireland
Department of Ophthalmology, The Royal Victoria Hospital, Belfast BT12 6BA, Northern Ireland, UK
Centre for Experimental Medicine, Queen’s University Belfast, Belfast BT7 1NN, Northern Ireland, UK
Author to whom correspondence should be addressed.
Authors contributed equally.
Academic Editor: Frans P.M. Cremers
Genes 2017, 8(11), 304;
Received: 8 September 2017 / Revised: 23 October 2017 / Accepted: 27 October 2017 / Published: 3 November 2017
There are an estimated 5000 people in Ireland who currently have an inherited retinal degeneration (IRD). It is the goal of this study, through genetic diagnosis, to better enable these 5000 individuals to obtain a clearer understanding of their condition and improved access to potentially applicable therapies. Here we show the current findings of a target capture next-generation sequencing study of over 750 patients from over 520 pedigrees currently situated in Ireland. We also demonstrate how processes can be implemented to retrospectively analyse patient datasets for the detection of structural variants in previously obtained sequencing reads. Pathogenic or likely pathogenic mutations were detected in 68% of pedigrees tested. We report nearly 30 novel mutations including three large structural variants. The population statistics related to our findings are presented by condition and credited to their respective candidate gene mutations. Rediagnosis rates of clinical phenotypes after genotyping are discussed. Possible causes of failure to detect a candidate mutation are evaluated. Future elements of this project, with a specific emphasis on structural variants and non-coding pathogenic variants, are expected to increase detection rates further and thereby produce an even more comprehensive representation of the genetic landscape of IRDs in Ireland. View Full-Text
Keywords: retina; genetics; ophthalmology; retinitis pigmentosa; genomics retina; genetics; ophthalmology; retinitis pigmentosa; genomics
Show Figures

Figure 1

MDPI and ACS Style

Dockery, A.; Stephenson, K.; Keegan, D.; Wynne, N.; Silvestri, G.; Humphries, P.; Kenna, P.F.; Carrigan, M.; Farrar, G.J. Target 5000: Target Capture Sequencing for Inherited Retinal Degenerations. Genes 2017, 8, 304.

AMA Style

Dockery A, Stephenson K, Keegan D, Wynne N, Silvestri G, Humphries P, Kenna PF, Carrigan M, Farrar GJ. Target 5000: Target Capture Sequencing for Inherited Retinal Degenerations. Genes. 2017; 8(11):304.

Chicago/Turabian Style

Dockery, Adrian, Kirk Stephenson, David Keegan, Niamh Wynne, Giuliana Silvestri, Peter Humphries, Paul F. Kenna, Matthew Carrigan, and G. Jane Farrar. 2017. "Target 5000: Target Capture Sequencing for Inherited Retinal Degenerations" Genes 8, no. 11: 304.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop